1 Min Read
May 10 (Reuters) - Pfizer Canada
* Health Canada has provided conditional approval of IBRANCE TM (palbociclib) and it is now available in canada Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.